Scholarly Works - Conferences
Conference
Journal of Clinical Oncology
·
February 1, 2022
335 Background: There is a critical need to develop effective therapeutic approaches for patients with esophageal cancer, a leading cause of cancer mortality. Recently, immune checkpoint blockade (ICB) has demonstrated modest sur ...
Full text
Cite
Conference
Journal of immunology and regenerative medicine
·
August 2021
IntroductionMacrophages are capable of extreme plasticity and their activation state has been strongly associated with solid tumor growth progression and regression. Although the macrophage response to extracellular matrix (ECM) isolated from norm ...
Full text
Cite
Conference
American Journal of Clinical Pathology
·
January 11, 2018
Full text
Cite
Conference
Journal of Clinical Oncology
·
May 20, 2017
4060 Background: PD-1 inhibitors in metastatic gastroesophageal cancer have demonstrated response rates of approximately 25%. Unfortunately, the majority of patients do not respond. Therefore, a rationale strategy of combining im ...
Full text
Cite
Conference
Journal of Clinical Oncology
·
May 20, 2017
e15598 Background: Esophageal adenocarcinoma (EAC) is a leading cause of cancer death, and current treatment options are extremely limited. Cell cycle regulators CDK6 and its homolog, CDK4, are known to be up-regulated in EAC and ...
Full text
Cite
Conference
Journal of Clinical Oncology
·
February 1, 2017
139 Background: PD-L1 expression has been reported in 40% of gastroesophageal cancers, but little data exists with regards to expression of other immune checkpoints. Here, we examined baseline expression levels for multiple immun ...
Full text
Cite
Conference
Journal of Clinical Oncology
·
May 20, 2016
Full text
Cite
Conference
Journal of Clinical Oncology
·
January 20, 2015
28 Background: The discovery of the link between H. pylori and gastric cancer may be the most direct proof that bacterial signaling and host response can result in carcinogenesis. Accumulating evidence supports that activation of ...
Full text
Cite
Conference
Molecular Cancer Research
·
November 1, 2014
AbstractBackground: The surgical rat model of end-to-side esophagojejunal anastomosis has proven utility in terms of its ability to replicate Barrett's carcinogenesis by inducing gastroduodenoesophageal refl ...
Full text
Cite
Conference
Journal of the American College of Surgeons
·
October 2014
Full text
Cite
Conference
Journal of Clinical Oncology
·
May 20, 2014
Full text
Cite
Conference
Cancer Research
·
October 1, 2013
AbstractBackground: Esophageal Adenocarcinoma (EAC) continues to rise in incidence, with prognosis remaining poor despite advances in multimodality therapy. Several novel target agents are now being explored ...
Full text
Cite